Generic Oncology Drugs Market to Display Growth at a CAGR of 6.2% in 2028

Generic Oncology Drugs Market to Display Growth at a
CAGR of 6.2% in 2028
Healthcare, Pharmaceuticals & Medical Devices
February 2019
Report Id : REP-GB-8961
Status : Publish
Category : Healthcare, Pharmaceuticals & Medical Devices
©2015 Future Market Insights, All Rights Reserved
About
Future Market Insights
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom
research reports, and consulting services. We deliver a complete packaged solution, which
combines current market intelligence, statistical anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC,
ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy,
Technology, Healthcare, and Retail.
We have a global presence with delivery centers across India specializing in providing global
research reports and country research reports. FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning
from every corner of the world to distill it to one thing – the perfect solution for our client.
Research Capabilities




Customized
Research
Syndicated
Research
Investment
Research
Social Media
Research
Customized Research
Syndicated Research
Investment Research
Social Media Research
Sector Coverage




Automotive and Transportation
Electronics, Semiconductor, and ICT
Retail and Consumer Products
Industrial Automation and Equipment




Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and Gas
Subscription Information
For detailed subscription information please contact
Hari. T (Sr. Manager - Global Business Development)
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Email: [email protected]
©2015 Future Market Insights, All Rights Reserved
2
Research Methodology (1/2)
Systematic Research Approach
1
Market profiling
2
Formulating discussion guide
3
Developing list of respondents
4
In-depth secondary research is used to
ascertain overall market size, top
industry players, top products, industry
associations, etc.
FMI formulates a detailed discussion
guide to conduct expert and industry
interviews
FMI develops a list of industry players
(manufacturers), distributors, retailers
and industry experts
Data collection
FMI conducts interviews with industry
experts, industry players, distributors
and retailers
Data validation
Data is validated by triangulation
method, wherein secondary, primary
and FMI analysis contribute to the final
data
5
6
Data analysis
Insights
7
Data is scrutinized using MS-Excel to
obtain qualitative and quantitative
insights about the industry
FMI delivers industry insights and
information in the required format
(PDF)
Data
Collection




Research &
Intelligence
Data Filter
& Analysis
Identifying key opinion leaders
Questionnaire design
In-depth interviews
Coverage across value chain
Actionable
Insights
A
Primary
Research






B
SOLUTION





Market participants
Key strengths
Product portfolio
Mapping as per value chain
Key focus segments
Primary Research #




Linkedin
Zoominfo
Salesforce
Avention
Business
Solution
Desk
Research
C
Key industry experts
Channel study
Developments
Market dynamics
Products
Conclusions
Company
Analysis
Secondary Research #




Company websites
Company annual
reports
White papers
Financial reports
Paid Publications#




Factiva
GBI
Genios
Meltwater
# includes sources of databases
©2015 Future Market Insights, All Rights Reserved
3
Generic Oncology Drugs Market Analysis
Increasing incidences of cancer have been detected, ascending from the proclivity for cigarettes and
tobacco among individuals. The number of cancer-infected patients is stimulated by viral infections,
carcinogens, lack of physical activities, genetic causes, age, and unhealthy eating habits. Recent
developments in the healthcare sector have broadened the scope of therapies for the treatment of
cancer by leveraging oncology.
Demand for generic oncology drugs has witnessed sheer increase, by dint of its property to treat
numerous types of cancer such as colorectal, lung, prostate, and multiple myeloma. With the ubiquity of
cancer, several health organizations across the world are hard pressed to develop a potent cure for the
treatment of cancer. In addition to this, a high number of deaths occurring on account of cancer has
amplified the research and development endeavors of medical organizations to prevent cancer
altogether.
Government initiatives to enhance the medical conditions by encouraging the development of novel
drugs has been a crucial factor for the rapid expansion of the generic oncology drugs market.
Furthermore, the reimbursement policies of government have equipped the manufacturers of the
industry with an attractive opportunity to boost the production of generic oncology drugs, which has
been a vital factor for the sustainable growth of the generic oncology drugs market. Analyzing a cohort of
these factors, the global generic oncology drugs market is poised to surpass a stunning CAGR of 6.2%
through 2028.
©2015 Future Market Insights, All Rights Reserved
4
Generic Oncology Drugs Market Analysis
North America Enjoys a Dominant Share in the Global Generic Oncology Drugs Market; Europe and
Asia-Pacific Next in Rank
Extensive analysis carried out on the generic oncology drugs market has presented region-wise insights
on the demand drivers, restraints, and opportunities that influence the growth of the market. Regions
analyzed in this report includes North America, Europe Asia-Pacific, and Rest of the World.
Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8961
Rising awareness of novel innovations and therapies for the treatment of cancer are projected to offer
lucrative growth opportunities to the generic oncology drugs market. Increase in the demand for generic
oncology drugs is further intensified in North America, on account of personalized medicines, novel
generic oncology drugs launches and a rising rate of strategic partnerships and collaborations in this
region. Following the footsteps of North America, Europe has witnessed affluent growth in the generic
oncology drugs market with the increasing consciousness of the generic oncology drugs for cancer
therapies.
Emerging economies of Asia-Pacific like India and China are expected to contribute to the growth of the
generic oncology drugs market, owing to the increasing cognizance of the disease and advancements in
the development of the generic oncology drugs.
©2015 Future Market Insights, All Rights Reserved
5
Generic Oncology Drugs Market Analysis
A Look at the Competitive Matrix for the Generic Oncology Drugs Market
The report opines that the burgeoning trend of mergers and acquisitions has been witnessed in the
generic oncology drugs market, which is expected to influence the growth of the global generic oncology
drugs market. Key players transforming the scenario of the generic oncology drugs market are Bayer
Healthcare AG, Amgen, Teva Pharmaceutical Industries, Pfizer, Boehringer Ingelheim GmbH, AstraZeneca,
Hoffmann-La Roche Ltd., Eli Lily and Company, ARIAD Pharmaceuticals, Inc., GlaxoSmithKline, CELGENE
Corporation, Novartis AG, Johnson and Johnson, AbbVie Inc., Merck & Co., and Sanofi, among others.
The business strategies and recent developments adopted by these players have been incorporated in
the report, which will help the stakeholders of this market gain valuable insights into the competitive
matrix of the global generic oncology drugs market.
Recent Developments in the Global Generic Oncology Drugs Market
CELGENE, Novartis, and Roche have been significant players in the generic oncology drugs market with
their far-reaching product portfolio and pipeline products and they procure a considerable market share.
Therapies and generic oncology drugs developed by Roche such as Avastin, Herceptin, and Rituxan
witnessed a rapid adoption.
©2015 Future Market Insights, All Rights Reserved
6
Generic Oncology Drugs Market Analysis
Strategic alliances formed by the companies of the generic oncology drugs market have aided them in
intensifying their endeavors towards developing generic oncology drugs with high efficacy. These
thoughtful strategies have proved lucrative for these players and helped them retain their supreme
position in the generic oncology drugs market.
Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-8961
Click here to
Order a free sample
©2015 Future Market Insights, All Rights Reserved
7
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
[email protected]
For media queries, contact the press office at
[email protected]
For other queries contact:
Hari. T (Sr. Manager - Global Business Development)
Future Market Insights: 3rd Floor,
207 Regent Street, London W1B 3HH
T: +44 20 7692 8790 | D: +44 20 3287 4268
Email: [email protected]
Thank You
Future Market Insights Global & Consulting Private Limited (FMI)
©2015 Future Market Insights, All Rights Reserved
8

Increasing incidences of cancer have been detected, ascending from the proclivity for cigarettes and tobacco among individuals. The number of cancer-infected patients is stimulated by viral infections, carcinogens, lack of physical activities, genetic causes, age, and unhealthy eating habits. Recent developments in the healthcare sector have broadened the scope of therapies for the treatment of cancer by leveraging oncology.

Download Report